| Announce Date | 11/04/2025 |
| EPS Normalized Actual | $0.19 (Beat by $0.0133) |
| EPS GAAP Actual | $0.19 (Beat by $0.0133) |
| Revenue Actual | $0.2001B |
| Revenue Surprise | Beat by $200.1M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.3044 |
| EPS GAAP Estimate | $0.3044 |
| Revenue Estimate | $0.2033749B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 1.19 | 7.09 | 1.16694 | 1.20696 | 1 |
| Dec 2026 | 1.22643 | 6.88 | 1.12436 | 1.46201 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.05 | -0.2392 | 0.2001B | 8.65% | -6.18M |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 0.1622B | 1.05% | 162.2M |
| FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 0.182B | 5.05% | 182M |
| FQ3 2024 (Sep 2024) | 0.12 | 0.12 | 0.1792B | 3.29% | 179.2M |
| FQ1 2016 (Mar 2016) | -0.23 | -0.23 | 0.093913B | 100% | 93.91M |
| FQ2 2016 (Jun 2016) | 0 | 0 | 0.277554B | 100% | 277.55M |
| FQ2 2024 (Jun 2024) | 0.071 | 0.071 | 0.1828B | -0.71% | 182.8M |
| FQ1 2024 (Mar 2024) | 0.0103 | 0.0103 | 0.1605B | -100133.02% | 160.5M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.3044
Consensus Revenue Estimates
0.2033749B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.31 | -- | 0.28485 | 0.32915 | 1 |
| FQ3 2027 (Sep 2027) | 0.29 | -- | 0.27859 | 0.31814 | 1 |
| FQ2 2027 (Jun 2027) | 0.26 | -- | 0.24977 | 0.28523 | 1 |
| FQ1 2027 (Mar 2027) | 0.12 | -- | 0.11528 | 0.13164 | 1 |
| FQ4 2026 (Oct 2026) | 0.3804 | -- | 0.34078 | 0.44857 | 1 |
| FQ3 2026 (Jul 2026) | 0.3649 | -- | 0.3269 | 0.43029 | 1 |
| FQ2 2026 (Jun 2026) | 0.3649 | 86.3 | 0.33203 | 0.43039 | 1 |
| FQ1 2026 (Mar 2026) | 0.201 | 114.93 | 0.18289 | 0.23708 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.23B | -- | 0.22B | 0.25B | 2 |
| FQ3 2027 (Sep 2027) | 0.23B | -- | 0.22B | 0.24B | 2 |
| FQ2 2027 (Jun 2027) | 0.23B | -- | 0.22B | 0.24B | 2 |
| FQ1 2027 (Mar 2027) | 0.18B | -- | 0.17B | 0.19B | 2 |
| FQ4 2026 (Oct 2026) | 0.21B | -- | 0.2B | 0.24B | 2 |
| FQ3 2026 (Jul 2026) | 0.22B | -- | 0.2B | 0.25B | 2 |
| FQ2 2026 (Jun 2026) | 0.22B | 8.01 | 0.2B | 0.25B | 2 |
| FQ1 2026 (Mar 2026) | 0.18B | 10.43 | 0.17B | 0.21B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
4
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.2892 | 0.05 | -0.2392 | -478.4% |
| FQ1 2025 (Mar 2025) | -0.03 | -0.03 | 100% | |
| FQ4 2024 (Dec 2024) | -0.26 | -0.26 | 100% | |
| FQ3 2024 (Sep 2024) | 0.12 | 0.12 | 100% | |
| FQ1 2016 (Mar 2016) | -0.23 | -0.23 | 100% | |
| FQ2 2016 (Jun 2016) | 0 | 0 | NAN% | |
| FQ2 2024 (Jun 2024) | 0.071 | 0.071 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0103 | 0.0103 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0.21B | $0.2B | $-6.18M | -3.09% |
| FQ1 2025 (Mar 2025) | $0B | $0.16B | $162.2M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.18B | $182M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.18B | $179.2M | 100% |
| FQ1 2016 (Mar 2016) | $0B | $0.09B | $93.91M | 100% |
| FQ2 2016 (Jun 2016) | $0B | $0.28B | $277.55M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.18B | $182.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.16B | $160.5M | 100% |